A bill that would require Iowa insurance plans to cover biomarker testing when used to diagnose, treat, manage or monitor cancer and other diseases is headed to Gov. Reynolds' desk.
Biomarker testing checks for certain genes or proteins that may be linked to certain diseases. Advocates say it could help doctors diagnose diseases earlier.
House File 2668 would increase access to biomarker testing, ensure Iowans covered by Medicaid and state regulated insurance plans have coverage for testing when medically appropriate.
Supporters say that would enable more patients to access the most effective treatments for their disease, hopefully leading to better health outcomes, improved quality of life and reduced costs.
The bill passed the House 97-1 on Monday, after lawmakers agreed to a Senate amendment to change the definition of when insurance companies have to pay for biomarker testing that has shown to provide meaningful information to guide treatment decisions that can lead to better health outcomes. The definition was changed to reflect language upon between patient advocacy groups and the health insurance industry.
California insurers must give discounts for wildfire mitigation. Have homeowners benefited? [The Sacramento Bee]
Euclid Programs Launches Marine Cargo Program for North American Insureds
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News